---
title: "ETON: Record Q2 revenue and raised 2026 guidance reflect strong rare disease portfolio momentum"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295841094.md"
description: "Q2 2026 saw 99% revenue growth to $37.6M, with net income of $11.6M and Adjusted EBITDA of $16.2M. Guidance for 2026 revenue was raised to over $145M, driven by strong rare disease portfolio performance and new product launches.Original document: Eton Pharmaceuticals, Inc. [ETON] SEC 8-K Current Report — Aug. 13 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T20:19:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295841094.md)
  - [en](https://longbridge.com/en/news/295841094.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295841094.md)
generator: "portal-rs"
---

# ETON: Record Q2 revenue and raised 2026 guidance reflect strong rare disease portfolio momentum

Q2 2026 saw 99% revenue growth to $37.6M, with net income of $11.6M and Adjusted EBITDA of $16.2M. Guidance for 2026 revenue was raised to over $145M, driven by strong rare disease portfolio performance and new product launches.

Original document: Eton Pharmaceuticals, Inc. \[ETON\] SEC 8-K Current Report — Aug. 13 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ETON.US](https://longbridge.com/en/quote/ETON.US.md)

## Related News & Research

- [Eton Pharmaceuticals (ETON) Faces A Valuation Test Following Its Rare Disease Growth Narrative](https://longbridge.com/en/news/297622328.md)
- [PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M](https://longbridge.com/en/news/297670548.md)
- [Eton Pharmaceuticals Director Sold Shares Worth Over $2.9M](https://longbridge.com/en/news/297369093.md)
- [Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference | ETON Stock News](https://longbridge.com/en/news/297172133.md)
- [Eton Pharmaceuticals (NASDAQ:ETON) Insider Sells 25,000 Shares of Stock](https://longbridge.com/en/news/296877759.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**